Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Saline Enhanced Radiofrequency (SERF) VT Ablation Early Feasibility Study (EFS)

NCT03628534 is registered in ClinicalTrials.gov with Thermedical, Inc. as lead sponsor.

NCT NCT03628534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03628534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Saline Enhanced Radiofrequency (SERF) VT Ablation Early Feasibility Study (EFS)
Lead sponsor
Thermedical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2018
Completion date
July 31, 2022
Enrollment
16 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arrythmia, cardiovascular diseases, heart diseases, ventricular tachycardia